These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 9740437

  • 1. The ultrastructure of human endometrium is altered by administration of intrauterine levonorgestrel.
    Pakarinen PI, Lähteenmäki P, Lehtonen E, Reima I.
    Hum Reprod; 1998 Jul; 13(7):1846-53. PubMed ID: 9740437
    [Abstract] [Full Text] [Related]

  • 2. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.
    Critchley HO, Wang H, Jones RL, Kelly RW, Drudy TA, Gebbie AE, Buckley CH, McNeilly AS, Glasier AF.
    Hum Reprod; 1998 May; 13(5):1218-24. PubMed ID: 9647550
    [Abstract] [Full Text] [Related]

  • 3. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
    Critchley HO, Wang H, Kelly RW, Gebbie AE, Glasier AF.
    Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
    Pakarinen PI, Suvisaari J, Luukkainen T, Lähteenmäki P.
    Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism?
    Mandelin E, Koistinen H, Koistinen R, Affandi B, Seppälä M.
    Hum Reprod; 1997 Dec; 12(12):2671-5. PubMed ID: 9455833
    [Abstract] [Full Text] [Related]

  • 8. Local levonorgestrel regulation of androgen receptor and 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrium.
    Burton KA, Henderson TA, Hillier SG, Mason JI, Habib F, Brenner RM, Critchley HO.
    Hum Reprod; 2003 Dec; 18(12):2610-7. PubMed ID: 14645180
    [Abstract] [Full Text] [Related]

  • 9. Hormonal intrauterine devices.
    Rybo G, Andersson K, Odlind V.
    Ann Med; 1993 Apr; 25(2):143-7. PubMed ID: 8489751
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Management of Endometrial Hyperplasia With a Levonorgestrel-Releasing Intrauterine System: A Korean Gynecologic-Oncology Group Study.
    Kim MK, Seong SJ, Kim JW, Jeon S, Choi HS, Lee IH, Lee JH, Ju W, Song ES, Park H, Ryu HS, Lee C, Kang SB.
    Int J Gynecol Cancer; 2016 May; 26(4):711-5. PubMed ID: 26905333
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Chin J, Konje JC, Hickey M.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD007245. PubMed ID: 19821400
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.